CAS 280-75-1

3-Oxa-7-azabicyclo[3.3.1]nonane

Description:

3-Oxa-7-azabicyclo[3.3.1]nonane, also known by its CAS number 280-75-1, is a bicyclic organic compound characterized by its unique structure that includes both nitrogen and oxygen atoms within its ring system. This compound features a bicyclic framework consisting of a seven-membered ring that incorporates an oxygen atom and a nitrogen atom, contributing to its heterocyclic nature. The presence of these heteroatoms can influence the compound's chemical reactivity and properties, such as solubility and polarity. Typically, compounds of this type may exhibit interesting biological activities, making them of interest in medicinal chemistry and drug design. The bicyclic structure can also impart strain, which may affect the stability and reactivity of the compound. Additionally, 3-Oxa-7-azabicyclo[3.3.1]nonane may participate in various chemical reactions, including nucleophilic substitutions and cycloadditions, due to the presence of functional groups associated with the nitrogen and oxygen atoms. Overall, this compound represents a fascinating example of heterocyclic chemistry with potential applications in various fields.

Formula: C₇H₁₃NO

Synonyms:

• Pydine

3-Oxa-7-azabicyclo[3.3.1]nonane

CAS: 280-75-1

Formula: C₇H₁₃NO

Purity: 97%

Color and Shape: Solid

Molecular weight: 127.1842

Ref: IN-DA003JUJ

3-Oxa-7-azabicyclo[3.3.1]nonane

CAS: 280-75-1

3-Oxa-7-azabicyclo[3.3.1]nonane

Purity: 95%

Molecular weight: 127.19g/mol

Ref: 54-OR1072076

3-Oxa-7-azabicyclo[3.3.1]nonane

CAS: 280-75-1

Purity: 97%

Molecular weight: 127.1869965

Ref: 10-F760873

3-Oxa-7-azabicyclo[3.3.1]nonane

CAS: 280-75-1

3-Oxa-7-azabicyclo[3.3.1]nonane is a linker that contains a hydroxyl group, heterocycle, intramolecular hydrogen, and fluorine. It has been shown to be an effective inhibitor of the HIV protease enzyme in vitro, although it is not active against other enzymes such as the human serum albumin or cytochrome P450. 3-Oxa-7-azabicyclo[3.3.1]nonane binds to the active site of the HIV protease by forming hydrogen bonds with amino acids near the active site and by stabilizing the conformation of its piperidine ring. This drug also has an axial orientation with respect to its fluoroquinolone plane and benzyl group that makes it stereoisomeric with 2 possible configurations: cis or trans.

Formula: C₇H₁₃NO

Purity: Min. 95%

Molecular weight: 127.18 g/mol

Ref: 3D-AAA28075